首页> 外国专利> Method for prediction based on genomic Apoi / ciii-polymorphier the development of atherosclerosis and kit for use therein

Method for prediction based on genomic Apoi / ciii-polymorphier the development of atherosclerosis and kit for use therein

机译:基于Apoi / ciii-polymorphier基因组预测动脉粥样硬化发展的方法及其中使用的试剂盒

摘要

The invention offers an early detection method for atherosclerosis using genetic analysis to detect a polymorphisms shown to be correlated with this disease which are proximal to the apolipoprotein AI (apoAI) and aplipoprotein CIII (apoCIII) gene complex. All individuals with a 300 bp deletion 4 kb upstream of the apoAI gene are destined to experience severe atherosclerotic symptomologies. Individuals with a polymorphism 5.4 kb 5' of the apoAI gene or a PvuII polymorphism in the first intron of the apoCIII gene also seem to be at greater risk. A haplotype with MspI and XmnI/7.2 polymorphisms in this general region seem to be protected. Additional polymorphic sites in the DNA sequence associated with the apoAI/CIII gene complex provide a means for genetically fingerprinting individuals, and for identifying persons at risk with respect to disorders relating to lipid metabolism and transport.
机译:本发明提供了一种使用遗传分析的动脉粥样硬化的早期检测方法,以检测与该疾病相关的多态性,该多态性与载脂蛋白AI(apoAI)和脂蛋白CIII(apoCIII)基因复合体最接近。所有在apoAI基因上游4 kb处缺失300 bp的个体注定会出现严重的动脉粥样硬化症状。具有apoAIIII基因的5.4 kb 5'多态性或apoCIII基因的第一个内含子中的PvuII多态性的个体似乎也处于较高的风险中。在这个一般区域具有MspI和XmnI / 7.2多态性的单倍型似乎受到保护。与apoAI / CIII基因复合物相关的DNA序列中的其他多态性位点提供了对个体进行基因指纹识别和鉴定与脂质代谢和运输相关的疾病风险的人的手段。

著录项

  • 公开/公告号DK610386A

    专利类型

  • 公开/公告日1987-02-17

    原文格式PDF

  • 申请/专利权人 BIOTECHNOLOGY RESEARCH PARTNERS LTD.;

    申请/专利号DK19860006103

  • 发明设计人 FROSSARD PHILIPPE M.;

    申请日1986-12-17

  • 分类号C12Q1/00;C12N15/00;

  • 国家 DK

  • 入库时间 2022-08-22 07:20:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号